Frozen blood products: Clinically effective and potentially ideal for remote Australia

Anaesthesia and Intensive Care

Volumn 41, Issue 1, 2013, Pages 10-19

  Holey, A ^a,b,c,d,e   Marks, D C ^a,b,c   Johnson, L ^a,b,c   Reade, M C ^a,b,c,d,f   Badloe, J F ^a,b,c   Noorman, F ^a,b,c  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b Sanquin Bloedbank Regio Zuidwest Rotterdam   (Netherlands)

^c AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e Royal Australian Navy   (Australia)

^f Army Malaria Research Unit   (Australia)

Author keywords

Cryopreserved; Deep frozen; Dimethyl sulfoxide; Glycerol; Plasma; Platelets; Red blood cells; Remote; Transfusion

Indexed keywords

BLOOD SUBSTITUTE; CRYOPROTECTIVE AGENT; DIMETHYL SULFOXIDE; FRESH FROZEN PLASMA; GLYCEROL; HETASTARCH; LIQUID NITROGEN; POVIDONE;

ARMY; AUSTRALIA; BACTERIUM CONTAMINATION; BIOLOGICAL ACTIVITY; BLEEDING; BLOOD BANK; BLOOD SAFETY; BLOOD STORAGE; BLOOD TRANSFUSION; CLINICAL EFFECTIVENESS; COLD INJURY; CRYOPRESERVATION; DISEASE TRANSMISSION; ERYTHROCYTE; FREEZE THAWING; FREEZING; GEOGRAPHY; GRAFT VERSUS HOST REACTION; HEADACHE; HEMOSTASIS; HUMAN; INTRAVASCULAR HEMOLYSIS; NAUSEA; NETHERLANDS; RESUSCITATION; REVIEW; SHELF LIFE; THAWING; THROMBOCYTE; THROMBOELASTOGRAPHY; VASOCONSTRICTION; BLOOD COMPONENT THERAPY; ERYTHROCYTE TRANSFUSION; METHODOLOGY; MILITARY MEDICINE; TIME;

AUSTRALIA; BLOOD BANKS; BLOOD COMPONENT TRANSFUSION; BLOOD PRESERVATION; BLOOD TRANSFUSION; CRYOPRESERVATION; ERYTHROCYTE TRANSFUSION; HEMORRHAGE; HUMANS; MILITARY MEDICINE; TIME FACTORS;

MLCS; MLOWN;

EID: 84874404751     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1304100104     Document Type: Review

References (77)

1. Pacheco LD, Saade GR, Costantine MM, Clark SL, Hankins GDV. The role of massive transfusion protocols in obstetrics. Am J Perinatol 2012; Epub ahead of print.
2. Mell MW, O'Neil AS, Callcut RA, Acher CW, Hoch JR, Tefera G et al. Effect of early plasma transfusion on mortality in patients with ruptured abdominal aortic aneurysm. Surgery 2010; 148:955-962.
3. Cheung FK, Lau JY. Management of massive peptic ulcer bleeding. Gastroenterol Clin North Am 2009; 38:231-243.
4. Hearnshaw S, Travis S, Murphy M. The role of blood transfusion in the management of upper and lower intestinal tract bleeding. Best Pract Res Clin Gastroenterol 2008; 22:355-371.
5. McLintock C, James AH. Obstetric hemorrhage. J Thromb Haemost 2011; 9:1441-1451.
6. Snegovskikh D, Clebone A, Norwitz E. Anesthetic management of patients with placenta accreta and resuscitation strategies for associated massive hemorrhage. Curr Opin Anaesthesiol 2011; 24:274-281.
7. Santoso JT, Saunders BA, Grosshart K. Massive blood loss and transfusion in obstetrics and gynecology. Obstet Gynecol Surv 2005; 60:827-837.
8. Riha GM, Schreiber MA. Update and new developments in the management of the exsanguinating patient. J Intensive Care Med 2011; Epub ahead of print.
9. Scalea TM. Hemostatic resuscitation for acute traumatic coagulopathy. Scand J Trauma Resusc Emerg Med 2011; 19:2.
10. Sihler KC, Napolitano LM. Complications of massive transfusion. Chest 2010; 137:209-220.
11. Sihler KC, Napolitano LM. Massive transfusion: New insights. Chest 2009; 136:1654-1667.
12. Shaz BH, Dente CJ, Harris RS, MacLeod JB, Hillyer CD. Transfusion management of trauma patients. Anesth Analg 2009; 108:1760-1768.
13. Dries DJ. The contemporary role of blood products and components used in trauma resuscitation. Scand J Trauma Resusc Emerg Med 2010; 18:63.
14. Mitra B, Mori A, Cameron PA, Fitzgerald M, Paul E, Street A. Fresh frozen plasma (FFP) use during massive blood transfusion in trauma resuscitation. Injury 2010; 41:35-39.
15. Holcomb JB. Traditional transfusion practices are changing. Crit Care 2010; 14:162.
16. Davenport RA, Brohi K. Coagulopathy in trauma patients: Importance of thrombocyte function? Curr Opin Anaesthesiol 2009; 22:261-266.
17. Maani CV, DeSocio PA, Holcomb JB. Coagulopathy in trauma patients: What are the main influence factors? Curr Opin Anaesthesiol 2009; 22:255-260.
18. Spinella PC, Holcomb JB. Resuscitation and transfusion principles for traumatic hemorrhagic shock. Blood Rev 2009; 23:231- 240.
19. Cotton BA, Gunter OL, Isbell J, Au BK, Robertson AM, Morris JA Jr et al. Damage control hematology: The impact of a trauma exsanguination protocol on survival and blood product utilization. J Trauma 2008; 64:1177-1182.
20. Borgman MA, Spinella PC, Perkins JG, Grathwohl KW, Repine T, Beekley AC et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007; 63:805-813.
21. Perkins JG, Cap AP, Spinella PC, Blackbourne LH, Grathwohl KW, Repine TB et al. An evaluation of the impact of apheresis platelets used in the setting of massively transfused trauma patients. J Trauma 2009; 66:S77-84; S84-5.
22. Holcomb JB, Spinella PC. Optimal use of blood in trauma patients. Biologicals 2010; 38:72-77.
23. Holcomb JB, Wade CE, Michalek JE, Chisholm GB, Zarzabal LA, Schreiber MA et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 2008; 248:447-458.
24. Rosenblatt MS, Hirsch EF, Valeri CR. Frozen red blood cells in combat casualty care: Clinical and logistical considerations. Mil Med 1994; 159:392-397.
25. van der Meer PF, de Korte D. Platelet preservation: Agitation and containers. Transfus Apher Sci 2011; 44:297-304.
26. Spinella PC, Perkins JG, Grathwohl KW, Beekley AC, Holcomb JB. Warm fresh whole blood is independently associated with improved survival for patients with combat-related traumatic injuries. J Trauma 2009; 66:S69-76.
27. Bowling F, Pennardt A. The use of fresh whole blood transfusions by the SOF medic for hemostatic resuscitation in the austere environment. J Spec Oper Med 2010; 10:25-35.
28. Makley AT, Goodman MD, Friend LA, Deters JS, Johannigman JA, Dorlac WC et al. Resuscitation with fresh whole blood ameliorates the inflammatory response after hemorrhagic shock. J Trauma 2010; 68:305-311.
29. Valeri CR, Ragno G. An approach to prevent the severe adverse events associated with transfusion of FDA-approved blood products. Transfus Apher Sci 2010; 42:223-333.
30. Holley AD. Synthetic blood products: Science fiction or coming to an ICU near you? Crit Care Resusc 2008; 10:253-256.
31. Winslow RM. Red cell substitutes. Semin Hematol 2007; 44:51-59.
32. K luger R. Red cell substitutes from hemoglobin - do we start all over again? Curr Opin Chem Biol 2010; 14:538-543.
33. Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: A meta-analysis. JAMA 2008; 299:2304- 2312.
34. Inaba K. Freeze-dried plasma. J Trauma 2011; 70:S57-58.
35. Noorman F, Strelitski R, Badloe JF. Lyophilized plasma, an alternative to 4°C stored thawed plasma for the early treatment of trauma patients with (massive) blood loss in military theatre. Transfusion 2012; 52:SP7.
36. Schoenfeld H, Pruss A, Keller M, Schuster M, Meinck K, Neuner B et al. Lyophilised plasma: Evaluation of clotting factor activity over 6 days after reconstitution for transfusion. J Clin Pathol 2010; 63:726-730.
37. Cap AP, Perkins JG. Lyophilized platelets: Challenges and opportunities. J Trauma 2011; 70 (Suppl 5):S59-60.
38. Scott KL, Lecak J, Acker JP. Biopreservation of red blood cells: Past, present, and future. Transfus Med Rev 2005; 19:127-142.
39. Valeri CR, Ragno G. Cryopreservation of human blood products. Transfus Apher Sci 2006; 34:271-287.
40. Lecak J, Scott K, Young C, Hannon J, Acker JP. Evaluation of red blood cells stored at -80°C in excess of 10 years. Transfusion 2004; 44:1306-1313.
41. Henkelman S, Lagerberg JW, Graaff R, Rakhorst G, Van Oeveren W. The effects of cryopreservation on red blood cell rheologic properties. Transfusion 2010; 50:2393-2401.
42. Moore GL. Long-term storage and preservation of red blood cells. Biotechnology 1991; 19:31-46.
43. Stoll C, Wolkers WF. Membrane stability during biopreservation of blood cells. Transfus Med Hemother 2011; 38:89-97.
44. Johnson LN, Winter KM, Reid S, Hartkopf-Theis T, Marks DC. Cryopreservation of buffy-coat-derived platelet concentrates in dimethyl sulfoxide and platelet additive solution. Cryobiology 2011; 62:100-106.
45. Lelkens CC, Koning JG, de Kort B, Floot IB, Noorman F. Experiences with frozen blood products in the Netherlands military. Transfus Apher Sci 2006; 34:289-298.
46. Noorman FBJ. -80°C Frozen platelets, efficient logistics, available, compatible, safe and effective in the treatment of trauma patients with or without massive blood loss in military theatre. Transfusion 2012; 52:SP383.
47. Noorman FBJ. -80°C Frozen platelets are activated compared to 24 hour liquid stored platelets and quality of frozen platelets is unaffected by a quick preparation method (15 min) which can be used to prepare platelets for the early treatment of trauma patients in military theatre. Transfusion 2012; 52:SP23.
48. Noorman FBJ. -80°C Frozen red blood cells, plasma and platelets, efficient logistics, available, compatible, safe and effective in the treatment of trauma patients with or without massive blood loss in military theatre. Transfusion 2012; 52:SP7.
49. Polge C, Smith AU, Parkes AS. Revival of spermatozoa after vitrification and dehydration at low temperatures. Nature 1949; 164:666.
50. Smith AU. Prevention of haemolysis during freezing and thawing of red blood-cells. Lancet 1950; 2:910-911.
51. Holovati JL, Hannon JL, Gyongyossy-Issa MI, Acker JP. Blood preservation workshop: New and emerging trends in research and clinical practice. Transfus Med Rev 2009; 23:25-41.
52. Van Oss CJ, Giese RF, Norris J. Interaction between advancing ice fronts and erythrocytes. Mechanism of erythrocyte destruction upon freezing and influence of cryoprotective agents. Cell Biophys 1991; 18:253-261.
53. Lelkens CC, Noorman F, Koning JG, Truijens-de Lange R, Stekkinger PS, Bakker JC et al. Stability after thawing of RBCs frozen with the high- and low-glycerol method. Transfusion 2003; 43:157-164.
54. Rowe AW, Eyster E, Kellner A. Liquid nitrogen preservation of red blood cells for transfusion; a low glycerol-rapid freeze procedure. Cryobiology 1968; 5:119-128.
55. Valeri CR, Brodine CE. Current methods for processing frozen red cells. Cryobiology 1968; 5:129-135.
56. Valeri CR, Ragno G, Pivacek LE, Srey R, Hess JR, Lippert LE et al. A multicenter study of in vitro and in vivo values in human RBCs frozen with 40-percent (wt/vol) glycerol and stored after deglycerolization for 15 days at 4 degrees C in AS-3: Assessment of RBC processing in the ACP 215. Transfusion 2001; 41:933-939.
57. Valeri CR, Ragno G, Pivacek L, O'Neill EM. In vivo survival of apheresis RBCs, frozen with 40-percent (wt/vol) glycerol, deglycerolized in the ACP 215, and stored at 4 degrees C in AS-3 for up to 21 days. Transfusion 2001; 41:928-932.
58. Valeri CR, Khuri S, Ragno G. Nonsurgical bleeding diathesis in anemic thrombocytopenic patients: Role of temperature, red blood cells, platelets, and plasma-clotting proteins. Transfusion 2007; 47:206S-248S.
59. Valeri CR, Ragno G, Khuri S. Freezing human platelets with 6 percent dimethyl sulfoxide with removal of the supernatant solution before freezing and storage at -80 degrees C without postthaw processing. Transfusion 2005; 45:1890-1898.
60. Regan DM, Wofford JD, Wall DA. Comparison of cord blood thawing methods on cell recovery, potency, and infusion. Transfusion 2010; 50:2670-2675.
61. Dumont LJ, Cancelas JA, Dumont DF, Siegel AH, Szczepiorkowski ZM, Rugg N et al. A randomized controlled trial evaluating recovery and survival of 6% dimethyl sulfoxidefrozen autologous platelets in healthy volunteers. Transfusion 2012; Epub ahead of print.
62. Valeri CR, Macgregor H, Ragno G. Correlation between in vitro aggregation and thromboxane A2 production in fresh, liquid-preserved, and cryopreserved human platelets: Effect of agonists, pH, and plasma and saline resuspension. Transfusion 2005; 45:596-603.
63. K huri SF, Healey N, MacGregor H, Barnard MR, Szymanski IO, Birjiniuk V et al. Comparison of the effects of transfusions of cryopreserved and liquid-preserved platelets on hemostasis and blood loss after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1999; 117:172-183.
64. Barnard MR, MacGregor H, Ragno G, Pivacek LE, Khuri SF, Michelson AD et al. Fresh, liquid-preserved, and cryopreserved platelets: Adhesive surface receptors and membrane procoagulant activity. Transfusion 1999; 39:880-888.
65. Valeri CR, Giorgio A, Macgregor H, Ragno G. Circulation and distribution of autotransfused fresh, liquid-preserved and cryopreserved baboon platelets. Vox Sang 2002; 83:347-351.
66. Abstracts of the AABB Annual Meeting and TXPO. October 24-27, 2009. New Orleans, Louisiana, USA. Transfusion 2009; 49:1A-305A.
67. Hess Jr. Red cell freezing and its impact on the supply chain. Transfus Med 2004; 14:1-8.
68. Marshall LR, Campbell AL, Anderson JC, Davey MG. Routine freezing of red blood cells for transfusion in Western Australia. Pathology 1976; 8:281-288.
69. Erickson ML, Champion MH, Klein R, Ross RL, Neal ZM, Snyder EL. Management of blood shortages in a tertiary care academic medical center: The Yale-New Haven Hospital frozen blood reserve. Transfusion 2008; 48:2252-2263.
70. Moss GS, Valeri CR, Brodine CE. Clinical experience with the use of frozen blood in combat casualties. N Engl J Med 1968; 278:747-752.
71. van Stein D, Beckers EA, Sintnicolaas K, Porcelijn L, Danovic F, Wollersheim JA et al. Transfusion-related acute lung injury reports in the Netherlands: An observational study. Transfusion 2010; 50:213-220.
72. Middelburg RA, Van Stein D, Zupanska B, Uhrynowska M, Gajic O, Muniz-Diaz E et al. Female donors and transfusionrelated acute lung injury: A case-referent study from the International TRALI Unisex Research Group. Transfusion 2010; 50:2447-2454.
73. Wiersum-Osselton JC, Middelburg RA, Beckers EA, Van Tilborgh AJ, Zijlker-Jansen PY, Brand A et al. Male-only fresh-frozen plasma for transfusion-related acute lung injury prevention: Before-and-after comparative cohort study. Transfusion 2011; 51:1278-1283.
74. Beekley AC, Martin MJ, Spinella PC, Telian SP, Holcomb JB. Predicting resource needs for multiple and mass casualty events in combat: Lessons learned from combat support hospital experience in Operation Iraqi Freedom. J Trauma 2009; 66:S129-137.
75. Neuhaus SJ, Wishaw K, Lelkens C. Australian experience with frozen blood products on military operations. Med J Aust 2010; 192:203-205.
76. Valeri CR, Ragno G. Breakage rate for red blood cells frozen with 40 percent (wt/vol) glycerol in 800-mL polyvinylchloride plastic bags stored in rigid cardboard boxes at -80 degrees C. Transfusion 2005; 45:822-823.
77. Johnson LN, Reid SJ, Winter KM, Noorman F, Badloe JF, Holley A et al. The Australian experience with deep frozen blood products. Vox Sang 2012; 103:68-271.